Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study
Background: A large-scale Japanese study showed that low skeletal muscle index (SMI) and intramuscular fat (IMF) deposition are associated with hepatocellular carcinoma (HCC) survival. Here, we evaluated the effects of SMI and IMF on the survival of Indonesian HCC patients, whose characteristics differ from those of Japanese patients.
Methods: SMI and mean muscle attenuation (MA) were evaluated using computed tomography images of the third lumbar vertebra (L3) in a prospective cohort of 100 Indonesian HCC patients. Clinical, laboratory and body composition data were analysed using the Kaplan–Meier method and Cox regression model to investigate which factors are associated with prognosis.
Results: Of 100 patients, 31 were diagnosed with sarcopenia (L3 SMI value ≤36.2 cm 2 /m 2 for men and ≤29.6 cm 2 /m 2 for women), and 65 had IMF deposition (MA value ≤44.4 HU for men and ≤39.3 HU for women). These groups had shorter median survival than the reference groups (both P <0.0001). In multivariable analysis, sarcopenia (hazard ratio [HR], 1.921; P = 0.016), IMF deposition (HR, 3.580; P <0.001), Barcelona Clinic Liver Cancer (BCLC) stages C and D (HR: 2.396, P <0.01 and HR: 6.131, P <0.01, respectively), Japan Integrated Staging (JIS) score 4 (HR: 2.067, P = 0.020), and male gender (HR: 3.211, P <0.001) were independently associated with mortality.
Conclusion: Sarcopenia and IMF deposition showed superior value in combination with BCLC stage and JIS score for predicting the survival of Indonesian HCC patients. Increased awareness and strategies to prevent or reverse these factors might improve patient outcomes.
Figure 1
Figure 2
Figure 3
Posted 23 Dec, 2019
On 30 Dec, 2019
On 20 Dec, 2019
On 18 Dec, 2019
On 15 Dec, 2019
On 13 Dec, 2019
On 09 Dec, 2019
Received 07 Dec, 2019
On 28 Nov, 2019
On 26 Nov, 2019
Received 26 Nov, 2019
Invitations sent on 25 Nov, 2019
On 15 Nov, 2019
On 14 Nov, 2019
On 14 Nov, 2019
On 27 Oct, 2019
On 24 Oct, 2019
Received 24 Oct, 2019
On 24 Oct, 2019
Received 24 Oct, 2019
On 21 Oct, 2019
Invitations sent on 13 Oct, 2019
On 01 Oct, 2019
On 27 Sep, 2019
On 26 Sep, 2019
On 25 Sep, 2019
Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study
Posted 23 Dec, 2019
On 30 Dec, 2019
On 20 Dec, 2019
On 18 Dec, 2019
On 15 Dec, 2019
On 13 Dec, 2019
On 09 Dec, 2019
Received 07 Dec, 2019
On 28 Nov, 2019
On 26 Nov, 2019
Received 26 Nov, 2019
Invitations sent on 25 Nov, 2019
On 15 Nov, 2019
On 14 Nov, 2019
On 14 Nov, 2019
On 27 Oct, 2019
On 24 Oct, 2019
Received 24 Oct, 2019
On 24 Oct, 2019
Received 24 Oct, 2019
On 21 Oct, 2019
Invitations sent on 13 Oct, 2019
On 01 Oct, 2019
On 27 Sep, 2019
On 26 Sep, 2019
On 25 Sep, 2019
Background: A large-scale Japanese study showed that low skeletal muscle index (SMI) and intramuscular fat (IMF) deposition are associated with hepatocellular carcinoma (HCC) survival. Here, we evaluated the effects of SMI and IMF on the survival of Indonesian HCC patients, whose characteristics differ from those of Japanese patients.
Methods: SMI and mean muscle attenuation (MA) were evaluated using computed tomography images of the third lumbar vertebra (L3) in a prospective cohort of 100 Indonesian HCC patients. Clinical, laboratory and body composition data were analysed using the Kaplan–Meier method and Cox regression model to investigate which factors are associated with prognosis.
Results: Of 100 patients, 31 were diagnosed with sarcopenia (L3 SMI value ≤36.2 cm 2 /m 2 for men and ≤29.6 cm 2 /m 2 for women), and 65 had IMF deposition (MA value ≤44.4 HU for men and ≤39.3 HU for women). These groups had shorter median survival than the reference groups (both P <0.0001). In multivariable analysis, sarcopenia (hazard ratio [HR], 1.921; P = 0.016), IMF deposition (HR, 3.580; P <0.001), Barcelona Clinic Liver Cancer (BCLC) stages C and D (HR: 2.396, P <0.01 and HR: 6.131, P <0.01, respectively), Japan Integrated Staging (JIS) score 4 (HR: 2.067, P = 0.020), and male gender (HR: 3.211, P <0.001) were independently associated with mortality.
Conclusion: Sarcopenia and IMF deposition showed superior value in combination with BCLC stage and JIS score for predicting the survival of Indonesian HCC patients. Increased awareness and strategies to prevent or reverse these factors might improve patient outcomes.
Figure 1
Figure 2
Figure 3